Skip to main content

Table 2 Reasons for regimen modification (n = 377)

From: Incidence and predictors of regimen-modification from first-line antiretroviral therapy in Thailand: a cohort study

Reasons Number (%) Days to regimen modification
(Median, IQRa)
Adverse effects 277 (73.5) 29 (5-55)
 Lipodystrophy 175 (63.2) 1493 (936-1946)
 Rash 49 (17.7) 29 (24-44)
 Hepatitis/Liver dysfunction 33 (11.9) 146 (56-315)
 Lactic acidosis 9 (3.3) 511 (410-573)
 Neuropathy 8 (2.9) 506 (286-574)
 Others 3 (1.1) 545 (388-1769)
Treatment failure 63 (16.7) 1147 (344-1246)
For TBb treatment 16 (4.2) 186 (93-248)
Pregnancy 10 (2.7) 868 (682-1643)
Others 2 (0.5) 527 (62-992)
Unknown 9 (2.4) 1085 (527-1705)
  1. aIQR, interquartile range.
  2. bTB, tuberculosis.